Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News

Dr. Jennifer Ashton speaks to Chris Wragge about symptoms of gout and a new study that shows the painful form of arthritis is showing up earlier than ever.

"Early Show" medical correspondent Dr. Jennifer Ashton talks to Rebecca Jarvis about how to recognize and avoid heat-related illnesses.

CBS News medical correspondent Dr. Jennifer Ashton answers health questions from viewers

Is the right diet for you all dependent on what blood type you are? Rebecca Jarvis speaks with Early Show Medical Correspondent, Dr

CBS News medical correspondent Dr. Jennifer Ashton answers viewer health questions on issues like high blood pressure, hydrating in the heat, lyme disease and food allergies.

More than three million Americans are infected with hepatitis C, a blood-borne virus that's linked to 12,000 deaths every year.

Despite conflicting report, a new study finds that there is no link between an increased risk of brain cancer and cell phone use among children and teens. Dr. Jennifer Ashton reports.

Dr. Jennifer Ashton reports on how gene mapping changed the life of one set of California twins, who from birth suffered one mysterious illness after another.

Rebecca Jarvis speaks to Dr. Jennifer Ashton and Susan G. Komen Foundation CEO Nancy Brinker about the right age and frequency of mammograms, the role of political will in cancer screening, and how to modify behavior to reduce the risk of breast cancer.

Chris Wragge speaks with Dr.

A new, less-invasive procedure could change how epilepsy is treated in many patients, particularly kids. Dr.

New research shows a link between older veterans who had a traumatic brain injury and an increased risk of dementia. Dr. Jennifer Ashton profiles a young Afghanistan veteran who could be at risk

CBS News medical correspondent Dr.

New concerns have been raised over the anti-smoking drug Chantix after a new analysis revealed an increase of heart problems. Dr. Jennifer Ashton reports

The FDA is beginning two days of hearings on the possible withdrawal of its approval of the drug Avastin for treating breast cancer. Dr